Buy Syros Pharmaceuticals Stock | SYRS Stock Price & Latest News | Public
SYRS

Syros Pharmaceuticals

$0.00 (0.00%)Today

    About SYRS

    Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.14
    -0.29
    -0.43
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.42

    Actual EPS
    Q4 2020

    Stats

    Market Cap$349,99M
    Volume40,6k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$14.69
    1 Year Low$4.26
    Open$7.65
    High$8.24
    Low$7.42

    Buy any stock with any amount of money.

    Download the App
    Download the app